PATENT CLAIM ANALYSIS

Application Number: 15743489
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["546", "065000"]

Abstract:
The present invention relates to the compounds of formula I, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states associated with cancers associated with protein kinases, to their use as medicaments for use in the production of inhibition of mTor, pi3k reducing effects in warm¬blooded animals such as humans.

Claim (Index 6):
A compound as claimed in any of  claims 1  to  4  for use in treating a neoplastic or proliferative or inflammatory disease, or a transplantation disorder, especially those caused by excess or inappropriate protein kinases.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.42222
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15325593', '14123934', '11294316', '12159742', '11378947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7988682562605293
- 35 USC 102 Novelty (BERT): 0.5554988624766425
- Combined Prediction Score: 0.7745313168821406
- Mean Citation Score: 292.0053919999998
- Max Citation Score: 508.21484
- Similarity Product: 274.3196730675125

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test